{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:15:20Z","timestamp":1788304520779,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":40,"publisher":"Springer US","isbn-type":[{"value":"9781071653753","type":"print"},{"value":"9781071653760","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5376-0_26","type":"book-chapter","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:34:20Z","timestamp":1788302060000},"page":"431-446","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Impact of Intravascular Hemolysis on Erythropoiesis in Sickle Cell Disease"],"prefix":"10.1007","author":[{"given":"Huan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"11","key":"26_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJM199709113371107","volume":"337","author":"HF Bunn","year":"1997","unstructured":"Bunn HF (1997) Mechanisms of disease - pathogenesis and treatment of sickle cell disease. N Engl J Med 337(11):762\u2013769","journal-title":"N Engl J Med"},{"issue":"5888","key":"26_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/300194a0","volume":"300","author":"M Coletta","year":"1982","unstructured":"Coletta M et al (1982) Kinetics of sickle hemoglobin polymerization in single red-cells. Nature 300(5888):194\u2013197","journal-title":"Nature"},{"issue":"9757","key":"26_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376(9757):2018\u20132031","journal-title":"Lancet"},{"issue":"3","key":"26_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest 127(3):750\u2013760","journal-title":"J Clin Invest"},{"issue":"12","key":"26_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nm1202-799","volume":"8","author":"CD Reiter","year":"2002","unstructured":"Reiter CD et al (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8(12):1383\u20131389","journal-title":"Nat Med"},{"key":"26_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.561917","volume":"11","author":"OT Gbotosho","year":"2020","unstructured":"Gbotosho OT, Kapetanaki MG, Kato GJ (2020) The worst things in life are free: the role of free Heme in sickle cell disease. Front Immunol 11:561917","journal-title":"Front Immunol"},{"issue":"1","key":"26_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1432-1033.1974.tb03386.x","volume":"43","author":"Z Hrkal","year":"1974","unstructured":"Hrkal Z, Vodr\u00e1zka Z, Kalousek I (1974) Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin. Eur J Biochem 43(1):73\u201378","journal-title":"Eur J Biochem"},{"issue":"7","key":"26_CR8","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","volume":"106","author":"V Hvidberg","year":"2005","unstructured":"Hvidberg V et al (2005) Identification of the receptor scavenging hemopexin-heme complexes. Blood 106(7):2572\u20132579","journal-title":"Blood"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.redox.2016.08.003","volume":"9","author":"JY Oh","year":"2016","unstructured":"Oh JY et al (2016) Absorbance and redox based approaches for measuring free heme and free hemoglobin in biological matrices. Redox Biol 9:167\u2013177","journal-title":"Redox Biol"},{"issue":"6","key":"26_CR10","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.4049\/jimmunol.1900047","volume":"203","author":"AM Thomas","year":"2019","unstructured":"Thomas AM et al (2019) Complement component C5 and TLR molecule CD14 mediate heme-induced thromboinflammation in human blood. J Immunol 203(6):1571\u20131578","journal-title":"J Immunol"},{"key":"26_CR11","doi-asserted-by":"crossref","unstructured":"Pastori V et al (2022) Role of nuclear receptors in controlling erythropoiesis. Int J Mol Sci 23(5)","DOI":"10.3390\/ijms23052800"},{"issue":"16","key":"26_CR12","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1182\/blood.2021011044","volume":"139","author":"AL Caulier","year":"2022","unstructured":"Caulier AL, Sankaran VG (2022) Molecular and cellular mechanisms that regulate human erythropoiesis. Blood 139(16):2450\u20132459","journal-title":"Blood"},{"issue":"4","key":"26_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011601","volume":"3","author":"E Dzierzak","year":"2013","unstructured":"Dzierzak E, Philipsen S (2013) Erythropoiesis: development and differentiation. Cold Spring Harb Perspect Med 3(4):a011601","journal-title":"Cold Spring Harb Perspect Med"},{"key":"26_CR14","doi-asserted-by":"crossref","unstructured":"Tang P, Wang HQ (2023) Regulation of erythropoiesis: emerging concepts and therapeutic implications. Hematology 28(1)","DOI":"10.1080\/16078454.2023.2250645"},{"issue":"1","key":"26_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0092-8674(95)90234-1","volume":"83","author":"H Wu","year":"1995","unstructured":"Wu H et al (1995) Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83(1):59\u201367","journal-title":"Cell"},{"issue":"12","key":"26_CR16","first-page":"5447","volume":"12","author":"GL Semenza","year":"1992","unstructured":"Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via denovo protein-synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12(12):5447\u20135454","journal-title":"Mol Cell Biol"},{"issue":"8","key":"26_CR17","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1182\/blood-2012-09-456079","volume":"121","author":"J Liu","year":"2013","unstructured":"Liu J et al (2013) Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. Blood 121(8):e43\u2013e49","journal-title":"Blood"},{"issue":"5","key":"26_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood.2019000430","volume":"134","author":"W Li","year":"2019","unstructured":"Li W et al (2019) Identification and transcriptome analysis of erythroblastic island macrophages. Blood 134(5):480\u2013491","journal-title":"Blood"},{"issue":"20","key":"26_CR19","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1182\/blood.2021011410","volume":"138","author":"H Zhang","year":"2021","unstructured":"Zhang H et al (2021) EpoR-tdTomato-Cre mice enable identification of EpoR expression in subsets of tissue macrophages and hematopoietic cells. Blood 138(20):1986\u20131997","journal-title":"Blood"},{"key":"26_CR20","doi-asserted-by":"crossref","unstructured":"Han Y et al (2023) Hemolysis-driven IFN\u03b1 production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease. Blood","DOI":"10.1182\/blood.2023021658"},{"key":"26_CR21","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1182\/blood.2021011629","volume":"138","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease. Blood 138:1162","journal-title":"Blood"},{"issue":"2","key":"26_CR22","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1172\/JCI116216","volume":"91","author":"RT Means Jr","year":"1993","unstructured":"Means RT Jr, Krantz SB (1993) Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 91(2):416\u2013419","journal-title":"J Clin Invest"},{"issue":"1","key":"26_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ni1146","volume":"6","author":"H Yoshida","year":"2005","unstructured":"Yoshida H et al (2005) Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 6(1):49\u201356","journal-title":"Nat Immunol"},{"issue":"11","key":"26_CR24","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1182\/blood.V112.11.4786.4786","volume":"112","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD et al (2008) In vitro effect of ribavirin and pegylated interferon on erythropoiesis. Blood 112(11):4786","journal-title":"Blood"},{"issue":"11","key":"26_CR25","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1182\/blood.V112.11.4577.4577","volume":"112","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD et al (2008) Anemia during pegylated interferon-ribavirin therapy results from both increase suppression of erythroid differentiation and hemolysis. Blood 112(11):4577\u20134577","journal-title":"Blood"},{"issue":"3","key":"26_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41418-017-0003-5","volume":"25","author":"MF Manchinu","year":"2018","unstructured":"Manchinu MF et al (2018) Deficiency in interferon type 1 receptor improves definitive erythropoiesis in Klf1 null mice. Cell Death Differ 25(3):589\u2013599","journal-title":"Cell Death Differ"},{"issue":"2","key":"26_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMra1802338","volume":"381","author":"SR Panch","year":"2019","unstructured":"Panch SR, Montemayor-Garcia C, Klein HG (2019) Hemolytic transfusion reactions. N Engl J Med 381(2):150\u2013162","journal-title":"N Engl J Med"},{"issue":"14","key":"26_CR28","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMc1910551","volume":"381","author":"T Sato","year":"2019","unstructured":"Sato T, Goto N, Tasaki T (2019) Hemolytic transfusion reactions. N Engl J Med 381(14):1396\u20131397","journal-title":"N Engl J Med"},{"key":"26_CR29","first-page":"3","volume":"3","author":"A Hill","year":"2017","unstructured":"Hill A et al (2017) Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Prim 3:3","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"26_CR30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/bjh.16473","volume":"189","author":"L Luzzatto","year":"2020","unstructured":"Luzzatto L (2020) PNH phenotypes and their genesis. Br J Haematol 189(5):802\u2013805","journal-title":"Br J Haematol"},{"issue":"9","key":"26_CR31","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3324\/haematol.2019.241141","volume":"105","author":"P Bianchi","year":"2020","unstructured":"Bianchi P, Fermo E (2020) Molecular heterogeneity of pyruvate kinase deficiency. Haematologica 105(9):2218\u20132228","journal-title":"Haematologica"},{"issue":"6","key":"26_CR32","first-page":"339","volume":"57","author":"V Helmst\u00e4dter","year":"1977","unstructured":"Helmst\u00e4dter V et al (1977) Acquired pyruvate kinase deficiency with hemolysis in preleukemia. Acta Haematol 57(6):339\u2013343","journal-title":"Acta Haematol"},{"issue":"13","key":"26_CR33","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1182\/blood-2005-04-1622","volume":"106","author":"R van Wijk","year":"2005","unstructured":"van Wijk R, van Solinge WW (2005) The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 106(13):4034\u20134042","journal-title":"Blood"},{"issue":"11","key":"26_CR34","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood.2019000944","volume":"136","author":"L Luzzatto","year":"2020","unstructured":"Luzzatto L, Ally M, Notaro R (2020) Glucose-6-phosphate dehydrogenase deficiency. Blood 136(11):1225\u20131240","journal-title":"Blood"},{"issue":"9606","key":"26_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G (2008) Glucose-6-phosphate dehydrogenase deficiency. Lancet 371(9606):64\u201374","journal-title":"Lancet"},{"key":"26_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12936-018-2509-9","volume":"17","author":"NJ White","year":"2018","unstructured":"White NJ (2018) Anaemia and malaria. Malar J 17:17","journal-title":"Malar J"},{"key":"26_CR37","doi-asserted-by":"crossref","unstructured":"Padua TA, Souza MC (2020) Heme on pulmonary malaria: friend or foe? Front Immunol 11","DOI":"10.3389\/fimmu.2020.01835"},{"issue":"9","key":"26_CR38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/ajh.26247","volume":"96","author":"H Yan","year":"2021","unstructured":"Yan H et al (2021) Comprehensive phenotyping of erythropoiesis in human bone marrow: evaluation of normal and ineffective erythropoiesis. Am J Hematol 96(9):1064\u20131076","journal-title":"Am J Hematol"},{"issue":"1","key":"26_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ajh.27145","volume":"99","author":"J Papoin","year":"2024","unstructured":"Papoin J et al (2024) Phenotypic and proteomic characterization of the human erythroid progenitor continuum reveal dynamic changes in cell cycle and in metabolic pathways. Am J Hematol 99(1):99\u2013112","journal-title":"Am J Hematol"},{"issue":"20","key":"26_CR40","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1016\/j.devcel.2023.07.018","volume":"58","author":"DJ Martell","year":"2023","unstructured":"Martell DJ et al (2023) RNA polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation. Dev Cell 58(20):2112","journal-title":"Dev Cell"}],"container-title":["Methods in Molecular Biology","Methods in Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5376-0_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:34:21Z","timestamp":1788302061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5376-0_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071653753","9781071653760"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5376-0_26","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}